Completed
Renal monitoring in people living with HIV
Learn MoreCompleted
Clindamycin, Primaquine vs.Trimethoprim Sulphamethoxazole
Learn MoreCompleted
Double Blind Comparison of ddI and Continued Zidovudine (AZT) in Therapy of Patients with HIV-Related Immune Suppression: Trial results
Learn MoreCompleted
A case-control study of novel bone imaging techniques and plasma markers in HIV-infected persons with or without fragility fractures
Learn MoreCompleted
Non-alcoholic fatty liver disease (NAFLD) in HIV: The role of nutritional interventions
Learn MoreCompleted
A pilot, prospective, open-label study to evaluate the safety and efficacy of Kaletra® monotherapy in HIV/HCV co-infected subjects
Learn MoreCompleted
Vicriviroc in combination treatment with an optimized ART regimen in HIV-infected treatment-experienced subjects
Learn MoreCompleted
A Multicenter, randomized, double-blind, double-dummy, phase 3 study of the safety and efficacy of Ritonavir-boosted Elvitegravir (EVG/r) versus Raltegravir (RAL)
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
